Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment

E Minos, RJ Barry, S Southworth, A Folkard… - Orphanet Journal of …, 2016 - Springer
Birdshot chorioretinopathy (BCR) is a rare form of chronic, bilateral, posterior uveitis with a
distinctive clinical phenotype, and a strong association with HLA-A29. It predominantly …

The immunopathogenesis of birdshot chorioretinopathy; a bird of many feathers

J Kuiper, A Rothova, J de Boer, T Radstake - Progress in retinal and eye …, 2015 - Elsevier
Birdshot chorioretinopathy (BSCR) is a bilateral chronic intraocular inflammation or posterior
uveitis that preferentially affects middle-aged Caucasians. BSCR is characterized by …

Birdshot chorioretinopathy: a review

E Bousquet, P Duraffour, L Debillon… - Journal of Clinical …, 2022 - mdpi.com
Birdshot chorioretinopathy (BSCR) is a bilateral chronic inflammation of the eye with no
extraocular manifestations. BSCR affects middle-aged individuals from European descent …

Functional outcome of macular edema in different retinal disorders

O Tomkins-Netzer, F Ismetova, A Bar… - Progress in retinal and …, 2015 - Elsevier
Macular edema accompanies many ocular pathologies, affecting visual function and is an
important factor in treatment decisions and disease outcome. Though visual acuity is …

Detection of choroid-and retina-antigen reactive CD8+ and CD4+ T lymphocytes in the vitreous fluid of patients with birdshot chorioretinopathy

JJW Kuiper, A Rothova, PAW Schellekens… - Human immunology, 2014 - Elsevier
Birdshot chorioretinopathy (BSCR), a progressive form of non-infectious uveitis, is the
strongest HLA-associated disease described to date, with> 95% of the patients displaying …

Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review

M Leclercq, M Le Besnerais, V Langlois, N Girszyn… - Clinical …, 2018 - Springer
Biotherapies appear as potential drugs for the treatment of inflammatory noninfectious
uveitis. In this report, we show that tocilizumab, an anti-IL-6 agent, greatly improved two …

High-dimensional profiling reveals heterogeneity of the Th17 subset and its association with systemic immunomodulatory treatment in non-infectious uveitis

FH Verhagen, S Hiddingh, R Rijken, A Pandit… - Frontiers in …, 2018 - frontiersin.org
Background: Non-infectious uveitis (NIU) is a severe intra ocular inflammation, which
frequently requires prompt systemic immunosuppressive therapy (IMT) to halt the …

Regulatory T cell therapy for uveitis: a new promising challenge

A Foussat, S Gregoire, N Clerget-Chossat… - Journal of Ocular …, 2017 - liebertpub.com
Uveitis is a sight-threatening primary intraocular inflammation of various origins in mainly
young and active patients. Due to the absence of biomarkers in most of the cases, the …

[HTML][HTML] Birdshot retinochoroidopathy

AT Vitale - Journal of Ophthalmic & Vision Research, 2014 - ncbi.nlm.nih.gov
Birdshot retinochoroidopathy (BSRC) is an uncommon, but well-characterized chronic,
bilateral posterior uveitis, which is uniquely associated with the human leukocyte antigen …

[PDF][PDF] Th17 and regulatory T cells are increased in blood of patients with birdshot chorioretinopathy

V Daien, F Mura, G Martin, R Audo, S Rivière… - Acta …, 2017 - academia.edu
Bachmann B, Schaub F & Cursiefen C (2016):[Treatment of corneal endothelial disorders by
DMEK and UT-DSAEK: indications, complications, results and follow-up]. Ophthalmologe …